Neurobiochemical changes from Taxol/Neupogen chemotherapy for metastatic breast carcinoma corresponds with suicidal depression

Cancer Letters

Volumn 110, Issue 1-2, 1996, Pages 163-167

  Cousins, Joseph P ^a   Harper, Gregory ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Chemotherapy; Depression; Magnetic resonance spectroscopy; Metastatic breast carcinoma; Neurobiochemical changes; Taxol

Indexed keywords

CHOLINE; CREATINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FLUOXYMESTERONE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; METHOTREXATE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TAMOXIFEN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CASE REPORT; DEPRESSION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; NEUROCHEMISTRY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SUICIDAL BEHAVIOR;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN CHEMISTRY; BREAST NEOPLASMS; DEPRESSION; FEMALE; FILGRASTIM; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PACLITAXEL; SUICIDE;

EID: 0030596033     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04486-2     Document Type: Article

References (11)

1. [1] Bottomley, P.A., Hardy, C.J., Cousins, J.P., Armstrong, M.A. and Wagle, W.A. (1990) AIDS Dementia Complex: brain high-energy phosphate metabolite deficits, Radiology, 176, 407-411.
2. [2] Cousins, J.P., Tomalski, W., Peters, T. and Wagle, W.A. (1994) NAA/choline and NAA/Cr as markers of metabolic changes in HIV+ patients (abstract) Proc, Soc. Magn. Reson., 2, 581.
3. [3] Jarvik, J.G., Lenkinski, R.E., Grossman, R.I., Gomori, J.M., Schnall, M.D. and Frank, I. (1993) Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation, Radiology, 186, 739-744.
4. [4] Barker, P.A., Lee, R.R. and McArthur, J.C. (1995) AIDS Dementia Complex: evaluation with proton MR spectroscopic imaging, Radiology, 195, 58-64.
5. [5] Miller, B.L., Moats, R.A., Shonk, T., Ernst, T., Wooley, S. and Ross, B.D. (1993) Alzheimer's disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy, Radiology, 187, 433-437.
6. [6] Shonk, T.K., Moats, R.A., Gifford, P., Michaelis, T., Mandingo, J.C., Izumi, J. and Ross, B.D. (1995) Probable Alzheimer's disease: diagnosis with proton MR spectroscopy, Radiology, 195, 65-72.
7. [7] Kreis, R., Ross, B.D., Farrow, N.A. and Ackerman, Z. (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with 1H MR spectroscopy, Radiology, 182, 19-27.
8. [8] Gupta, R.K., Saraswat, V.A., Poptani, H., Dhiman, R.K., Kohli, A., Gujral, R.B. and Naik, S.R. (1993) A magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure, Am. J. Gastroenterol., 88, 670-674.
9. [9] Ross, B.D., Jacobson, S., Villamil, F., Korula, J., Kreis, R., Ernst, T., Shonk, T. and Moats, R.A. (1994) Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities, Radiology, 193, 457-463.
10. [10] Haussinger, D., Laubenberger, J., vom Dahl, S., Ernst, T., Bayer, S., Langer, M., Gerok, W. and Hennig, J. (1994) Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy, Gastroenterology, 107, 1475-1480.
11. [11] Cousins, J.P. (1995) Clinical MR spectroscopy: fundamentals, current applications, and future potential, AJR, 164, 1337-1347.